Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Harrow, Inc.(HROW) | 3,990,000 | 3,990,000 | 0 | $83.35M | $179.39M | 29.92% | +$96.04M |
| TG Therapeutics, Inc.(TGTX) | 2,280,000 | 2,280,000 | 0 | $40.56M | $53.33M | 8.89% | +$12.77M |
| Ocular Therapeutix, Inc.(OCUL) | 5,307,500 | 5,025,000 | -282,500 | $36.30M | $43.72M | 7.29% | +$7.41M |
| Arvinas, Inc.(ARVN) | 555,000 | 1,255,000 | +700,000 | $14.77M | $30.91M | 5.16% | +$16.14M |
| Codexis, Inc.(CDXS) | 3,455,000 | 8,770,000 | +5,315,000 | $10.71M | $27.01M | 4.51% | +$16.30M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 515,000 | 500,000 | -15,000 | $21.15M | $26.20M | 4.37% | +$5.05M |
| Keros Therapeutics, Inc.(KROS) | 367,500 | 395,276 | +27,776 | $16.79M | $22.95M | 3.83% | +$6.16M |
| Immunome, Inc.(IMNM) | 1,102,500 | 1,237,500 | +135,000 | $13.34M | $18.09M | 3.02% | +$4.75M |
| Liquidia Corporation(LQDA) | 325,000 | 1,698,142 | +1,373,142 | $3.90M | $16.98M | 2.83% | +$13.08M |
| Eton Pharmaceuticals, Inc.(ETON) | 2,395,000 | 2,780,000 | +385,000 | $7.88M | $16.68M | 2.78% | +$8.80M |
| Edgewise Therapeutics, Inc.(EWTX) | 580,000 | 522,500 | -57,500 | $10.45M | $13.95M | 2.33% | +$3.50M |
| Cargo Therapeutics Inc | 555,700 | 541,437 | -14,263 | $9.12M | $11.83M | 1.97% | +$2.71M |
| Applied Therapeutics Inc' | 1,680,000 | 1,320,000 | -360,000 | $7.85M | $11.22M | 1.87% | +$3.37M |
| Vaxcyte, Inc.(PCVX) | 85,000 | 85,000 | 0 | $6.42M | $9.71M | 1.62% | +$3.29M |
| Nurix Therapeutics, Inc.(NRIX) | 418,928 | 420,000 | +1,072 | $8.74M | $9.44M | 1.57% | +$694.4K |
| Acelyrin Inc | 1,580,000 | 1,893,660 | +313,660 | $6.97M | $9.34M | 1.56% | +$2.37M |
| Trevi Therapeutics, Inc.(TRVI) | 2,645,000 | 2,567,990 | -77,010 | $7.88M | $8.58M | 1.43% | +$695.0K |
| Biodesix, Inc.(BDSX) | 4,020,000 | 3,815,000 | -205,000 | $6.15M | $6.97M | 1.16% | +$820.1K |
| Ginkgo Bioworks Holdings, Inc.CL A(DNA) | 0 | 820,202 | +820,202 | $0 | $6.68M | 1.11% | +$6.68M |
| Jasper Therapeutics, Inc.(JSPR) | 392,000 | 353,500 | -38,500 | $8.90M | $6.65M | 1.11% | -$2.25M |
| Xoma Corp Del | 250,000 | 250,000 | 0 | $5.92M | $6.62M | 1.10% | +$697.5K |
| Nuvalent Inc | 59,300 | 64,000 | +4,700 | $4.50M | $6.55M | 1.09% | +$2.05M |
| Newamsterdam Pharma Company ORDINARY SHARES | 315,000 | 335,000 | +20,000 | $6.05M | $5.56M | 0.93% | -$490.1K |
| UroGen Pharma Ltd.(URGN) | 412,000 | 404,100 | -7,900 | $6.91M | $5.13M | 0.86% | -$1.78M |
| Protagonist Therapeutics Inc | 105,000 | 105,000 | 0 | $3.64M | $4.72M | 0.79% | +$1.09M |
| Gossamer Bio, Inc.NOTE 5 000 6 0(GOSS) | 0 | 0 | 0 | $3.96M | $4.19M | 0.70% | +$231.2K |
| Cytokinetics, Incorporated(CYTK) | 198,500 | 75,300 | -123,200 | $10.75M | $3.98M | 0.66% | -$6.78M |
| Karyopharm Therapeutics IncNOTE 3 000 10 1 | 0 | 0 | 0 | $3.75M | $3.96M | 0.66% | +$213.5K |
| Gossamer Bio, Inc.(GOSS) | 3,910,000 | 3,665,010 | -244,990 | $3.52M | $3.71M | 0.62% | +$183.2K |
| Zentalis Pharmaceuticals, Inc.(ZNTL) | 0 | 967,000 | +967,000 | $0 | $3.56M | 0.59% | +$3.56M |
| Protara Therapeutics, Inc.(TARA) | 2,304,262 | 1,681,154 | -623,108 | $5.30M | $3.08M | 0.51% | -$2.22M |
| Rezolute, Inc.(RZLT) | 0 | 466,563 | +466,563 | $0 | $2.26M | 0.38% | +$2.26M |
| Catalyst Pharmaceuticals Inc | 640,000 | 112,500 | -527,500 | $9.91M | $2.24M | 0.37% | -$7.68M |
| AbCellera Biologics Inc.(ABCL) | 200,000 | 800,000 | +600,000 | $592.0K | $2.08M | 0.35% | +$1.49M |
| Lyell Immunopharma, Inc.(LYEL) | 1,670,000 | 1,395,000 | -275,000 | $2.42M | $1.93M | 0.32% | -$496.4K |
| Allakos Inc | 2,780,000 | 2,407,600 | -372,400 | $2.78M | $1.57M | 0.26% | -$1.21M |
| Relmada Therapeutics, Inc.(RLMD) | 600,000 | 480,000 | -120,000 | $1.80M | $1.56M | 0.26% | -$244.8K |
| PepGen Inc.(PEPG) | 0 | 179,200 | +179,200 | $0 | $1.53M | 0.26% | +$1.53M |
| Revance Therapeutics Inc | 0 | 275,000 | +275,000 | $0 | $1.43M | 0.24% | +$1.43M |
| Syros Pharmaceuticals Inc | 865,443 | 654,943 | -210,500 | $4.47M | $1.41M | 0.23% | -$3.06M |
| Aerovate Therapeutics Inc | 440,000 | 440,000 | 0 | $730.4K | $919.6K | 0.15% | +$189.2K |
| Regulus Therapeutics Inc | 1,475,000 | 535,000 | -940,000 | $2.63M | $840.0K | 0.14% | -$1.79M |
| iBio, Inc.(IBIO) | 375,000 | 375,000 | 0 | $791.3K | $832.5K | 0.14% | +$41.3K |
| Adagio Medical Holdings, Inc.(ADGM) | 0 | 110,571 | +110,571 | $0 | $285.3K | 0.05% | +$285.3K |
| 4d Molecular Therapeutics Inc | 345,750 | 0 | -345,750 | $7.26M | $0 | — | -$7.26M |
| Aligos Therapeutics Inc | 1,260,000 | 0 | -1,260,000 | $441.0K | $0 | — | -$441.0K |
| Design Therapeutics, Inc.(DSGN) | 205,000 | 0 | -205,000 | $686.8K | $0 | — | -$686.8K |
| Fulcrum Therapeutics, Inc.(FULC) | 285,000 | 0 | -285,000 | $1.77M | $0 | — | -$1.77M |
| Intellia Therapeutics, Inc.(NTLA) | 218,000 | 0 | -218,000 | $4.88M | $0 | — | -$4.88M |
| Iovance Biotherapeutics, Inc.(IOVA) | 897,000 | 0 | -897,000 | $7.19M | $0 | — | -$7.19M |
| Karyopharm Therapeutics Inc.(KPTI) | 1,425,000 | 0 | -1,425,000 | $1.24M | $0 | — | -$1.24M |
| Lexicon Pharmaceuticals, Inc.(LXRX) | 1,875,000 | 0 | -1,875,000 | $3.15M | $0 | — | -$3.15M |
| PMV Pharmaceuticals, Inc.(PMVP) | 475,000 | 0 | -475,000 | $769.5K | $0 | — | -$769.5K |
| Reneo Pharmaceuticals Inc | 165,000 | 0 | -165,000 | $249.2K | $0 | — | -$249.2K |
| Savara Inc.(SVRA) | 714,960 | 0 | -714,960 | $2.88M | $0 | — | -$2.88M |
| Ventyx Biosciences Inc | 1,190,000 | 0 | -1,190,000 | $2.75M | $0 | — | -$2.75M |
| Verastem, Inc.(VSTM) | 915,000 | 0 | -915,000 | $2.73M | $0 | — | -$2.73M |